{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:27:46Z","timestamp":1767677266069,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR4500\/PIB\/6\/676\/2012","BT\/MED\/30\/SP11290\/2015"],"award-info":[{"award-number":["BT\/PR4500\/PIB\/6\/676\/2012","BT\/MED\/30\/SP11290\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s13577-020-00476-x","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T11:04:29Z","timestamp":1609931069000},"page":"445-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a cell-based pathway modulator screening system to screen the targeted cancer therapeutic candidates"],"prefix":"10.1007","volume":"34","author":[{"given":"Ponmathi","family":"Panneerpandian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumaresan","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"476_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"476_CR2","doi-asserted-by":"publisher","unstructured":"Martin GS. Cell signaling and cancer. Cancer Cell. 2003. https:\/\/doi.org\/10.1016\/s1535-6108(03)00216-2.","DOI":"10.1016\/s1535-6108(03)00216-2"},{"key":"476_CR3","doi-asserted-by":"publisher","unstructured":"Sebolt-Leopold JS, English JM. Mechanisms of drug inhibition of signalling molecules. Nature. 2006. https:\/\/doi.org\/10.1038\/nature04874.","DOI":"10.1038\/nature04874"},{"key":"476_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0804-2","author":"KS Bhullar","year":"2018","unstructured":"Bhullar KS, Lagar\u00f3n NO, McGowan EM, et al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer. 2018. https:\/\/doi.org\/10.1186\/s12943-018-0804-2.","journal-title":"Mol Cancer"},{"key":"476_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.03.036","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013. https:\/\/doi.org\/10.1016\/j.cell.2013.03.036.","journal-title":"Cell"},{"key":"476_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064420","author":"CRT de Souza","year":"2013","unstructured":"de Souza CRT, Leal MF, Calcagno DQ, et al. MYC deregulation in gastric cancer and its clinicopathological implications. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0064420.","journal-title":"PLoS ONE"},{"key":"476_CR7","doi-asserted-by":"publisher","unstructured":"Johnson DG, Schneider-Broussard R. Role of E2F in cell cycle control and cancer. Front Biosci. 1998. https:\/\/doi.org\/10.2741\/a291.","DOI":"10.2741\/a291"},{"key":"476_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5493\/wjem.v5.i2.84","volume":"5","author":"MA Chiurillo","year":"2015","unstructured":"Chiurillo MA. Role of the Wnt\/\u03b2-catenin pathway in gastric cancer: an in-depth literature review. World J Exp Med. 2015;5:84\u2013102. https:\/\/doi.org\/10.5493\/wjem.v5.i2.84.","journal-title":"World J Exp Med"},{"key":"476_CR9","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.3748\/wjg.v21.i41.11673","volume":"21","author":"M Yang","year":"2015","unstructured":"Yang M, Huang C-Z. Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer. World J Gastroenterol. 2015;21:11673\u20139. https:\/\/doi.org\/10.3748\/wjg.v21.i41.11673.","journal-title":"World J Gastroenterol"},{"key":"476_CR10","doi-asserted-by":"publisher","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer. Cancer Cell. 2018. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.022.","DOI":"10.1016\/j.ccell.2018.03.022"},{"key":"476_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers5010015","author":"Y Kitajima","year":"2013","unstructured":"Kitajima Y, Miyazaki K. The critical impact of HIF-1\u03b1 on gastric cancer biology. Cancers (Basel). 2013. https:\/\/doi.org\/10.3390\/cancers5010015.","journal-title":"Cancers (Basel)"},{"key":"476_CR12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2434","author":"RA Busuttil","year":"2014","unstructured":"Busuttil RA, Zapparoli GV, Haupt S, et al. Role of p53 in the progression of gastric cancer. Oncotarget. 2014. https:\/\/doi.org\/10.18632\/oncotarget.2434.","journal-title":"Oncotarget"},{"key":"476_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-80","author":"W Kang","year":"2014","unstructured":"Kang W, Tong JHM, Chan AWH, et al. Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. J Transl Med. 2014. https:\/\/doi.org\/10.1186\/1479-5876-12-80.","journal-title":"J Transl Med"},{"key":"476_CR14","doi-asserted-by":"publisher","unstructured":"Sokolova O, Naumann M. NF-\u03baB signaling in gastric cancer. Toxins (Basel). 2017. https:\/\/doi.org\/10.3390\/toxins9040119.","DOI":"10.3390\/toxins9040119"},{"key":"476_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.01.017","author":"J Periasamy","year":"2014","unstructured":"Periasamy J, Muthuswami M, Rao DB, et al. Stratification and delineation of gastric cancer signaling by in vitro transcription factor activity profiling and integrative genomics. Cell Signal. 2014. https:\/\/doi.org\/10.1016\/j.cellsig.2014.01.017.","journal-title":"Cell Signal"},{"key":"476_CR16","unstructured":"Sherf BA, Navarro SL, Hannah RR, Wood KV. Promega corporation. Promega notes: dual-luciferaseTM reporter assay: an advanced co-reporter technology integrating firefly and renilla ruciferase. Promega Notes Mag Number 57. 1996."},{"key":"476_CR17","doi-asserted-by":"publisher","unstructured":"Xie W, Silvers R, Ouellette M, Wu Z, Lu Q, Li H, et al. A luciferase reporter gene system for high-throughput screening of \u03b3-Globin gene activators. Methods Mol. Biol. 2016. https:\/\/doi.org\/10.1007\/978-1-4939-3673-1_14.","DOI":"10.1007\/978-1-4939-3673-1_14"},{"key":"476_CR18","doi-asserted-by":"publisher","DOI":"10.4172\/1948-5956.1000198","author":"J Periasamy","year":"2013","unstructured":"Periasamy J, Muthuswami M, Ramesh V, et al. Nimesulide and celecoxib inhibits multiple oncogenic pathways in gastric cancer cells. J Cancer Sci Ther. 2013. https:\/\/doi.org\/10.4172\/1948-5956.1000198.","journal-title":"J Cancer Sci Ther"},{"key":"476_CR19","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2000.4605","author":"BW Dyer","year":"2000","unstructured":"Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem. 2000. https:\/\/doi.org\/10.1006\/abio.2000.4605.","journal-title":"Anal Biochem"},{"key":"476_CR20","doi-asserted-by":"publisher","unstructured":"Gossen M, Bonin AL, Bujard H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biotechnol. 1994. https:\/\/doi.org\/10.1016\/0167-7799(94)90101-5.","DOI":"10.1016\/0167-7799(94)90101-5"},{"key":"476_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1158\/1535-7163.MCT-07-2063","volume":"7","author":"S Handeli","year":"2008","unstructured":"Handeli S, Simon JA. A small-molecule inhibitor of Tcf\/\u03b2-catenin signaling down-regulates PPAR\u03b3 and PPAR\u03b4 activities. Mol Cancer Ther. 2008;7:521\u20139. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-2063.","journal-title":"Mol Cancer Ther"},{"key":"476_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2011.1","author":"K Vandyke","year":"2011","unstructured":"Vandyke K, Fitter S, Zannettino ACW. The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation. Blood Cancer J. 2011. https:\/\/doi.org\/10.1038\/bcj.2011.1.","journal-title":"Blood Cancer J"},{"key":"476_CR23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2769","author":"L Chesler","year":"2006","unstructured":"Chesler L, Schlieve C, Goldenberg DD, et al. Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma. Cancer Res. 2006. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2769.","journal-title":"Cancer Res"},{"key":"476_CR24","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2017020472","author":"B Bonavida","year":"2017","unstructured":"Bonavida B. Therapeutic YY1 inhibitors in cancer: all in one. Crit Rev Oncog. 2017. https:\/\/doi.org\/10.1615\/CritRevOncog.2017020472.","journal-title":"Crit Rev Oncog"},{"key":"476_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.11.048","author":"LM Deck","year":"2018","unstructured":"Deck LM, Hunsaker LA, Vander Jagt TA, et al. Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin. Eur J Med Chem. 2018. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.048.","journal-title":"Eur J Med Chem"},{"key":"476_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2685-3","author":"J Koroth","year":"2019","unstructured":"Koroth J, Nirgude S, Tiwari S, et al. Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines. BMC Complement Altern Med. 2019. https:\/\/doi.org\/10.1186\/s12906-019-2685-3.","journal-title":"BMC Complement Altern Med"},{"key":"476_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8090382","author":"L Cianfruglia","year":"2019","unstructured":"Cianfruglia L, Minnelli C, Laudadio E, et al. Side effects of curcumin: epigenetic and antiproliferative implications for normal dermal fibroblast and breast cancer cells. Antioxidants. 2019. https:\/\/doi.org\/10.3390\/antiox8090382.","journal-title":"Antioxidants"},{"key":"476_CR28","doi-asserted-by":"publisher","unstructured":"Mbese Z, Khwaza V, Aderibigbe BA. Curcumin and its derivatives as potential therapeutic agents in prostate, colon and breast cancers. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24234386.","DOI":"10.3390\/molecules24234386"},{"key":"476_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","author":"L Meijer","year":"1997","unstructured":"Meijer L, Borgne A, Mulner O, et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem. 1997. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.t01-2-00527.x.","journal-title":"Eur J Biochem"},{"key":"476_CR30","doi-asserted-by":"publisher","DOI":"10.3791\/2899","author":"D Wu","year":"2011","unstructured":"Wu D, Yotnda P. Induction and testing of hypoxia in cell culture. J Vis Exp. 2011. https:\/\/doi.org\/10.3791\/2899.","journal-title":"J Vis Exp"},{"key":"476_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104958","author":"S G\u00f3mez-Arnaiz","year":"2020","unstructured":"G\u00f3mez-Arnaiz S, Tate RJ, Grant MH. Cytotoxicity of cobalt chloride in brain cell lines\u2014a comparison between astrocytoma and neuroblastoma cells. Toxicol Vitr. 2020. https:\/\/doi.org\/10.1016\/j.tiv.2020.104958.","journal-title":"Toxicol Vitr"},{"key":"476_CR32","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.9b01474","author":"VK Tripathi","year":"2019","unstructured":"Tripathi VK, Subramaniyan SA, Hwang I. Molecular and cellular response of co-cultured cells toward cobalt chloride (CoCl2)-induced hypoxia. ACS Omega. 2019. https:\/\/doi.org\/10.1021\/acsomega.9b01474.","journal-title":"ACS Omega"},{"key":"476_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1635-5","author":"JH Lee","year":"2013","unstructured":"Lee JH, Choi SH, Baek MW, et al. CoCl2 induces apoptosis through the mitochondria- and death receptor-mediated pathway in the mouse embryonic stem cells. Mol Cell Biochem. 2013. https:\/\/doi.org\/10.1007\/s11010-013-1635-5.","journal-title":"Mol Cell Biochem"},{"key":"476_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.05.047","author":"S Nakajima","year":"2011","unstructured":"Nakajima S, Kato H, Takahashi S, et al. Inhibition of NF-\u03baB by MG132 through ER stress-mediated induction of LAP and LIP. FEBS Lett. 2011. https:\/\/doi.org\/10.1016\/j.febslet.2011.05.047.","journal-title":"FEBS Lett"},{"key":"476_CR35","doi-asserted-by":"publisher","first-page":"e77553","DOI":"10.1371\/journal.pone.0077553","volume":"8","author":"M Muthuswami","year":"2013","unstructured":"Muthuswami M, Ramesh V, Banerjee S, et al. Breast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras\/PI3K inhibition. PLoS ONE. 2013;8:e77553\u2013e77553. https:\/\/doi.org\/10.1371\/journal.pone.0077553.","journal-title":"PLoS ONE"},{"key":"476_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104695","author":"P Panneerpandian","year":"2020","unstructured":"Panneerpandian P, Devanandan HJ, Marimuthu A, et al. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells. Antivir Res. 2020. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104695.","journal-title":"Antivir Res"},{"key":"476_CR37","doi-asserted-by":"publisher","unstructured":"Capiod T, Shuba Y, Skryma R,  Prevarskaya N. Calcium signalling and cancer cell growth. 2007. https:\/\/doi.org\/10.1007\/978-1-4020-6191-2_15.","DOI":"10.1007\/978-1-4020-6191-2_15"},{"key":"476_CR38","doi-asserted-by":"publisher","unstructured":"Mekahli D, Bultynck G, Parys JB, de Smedt H, Missiaen L. Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb Perspect Biol. 2011. https:\/\/doi.org\/10.1101\/cshperspect.a004317.","DOI":"10.1101\/cshperspect.a004317"},{"key":"476_CR39","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1128\/MCB.25.11.4529-4540.2005","volume":"25","author":"P Baumeister","year":"2005","unstructured":"Baumeister P, Luo S, Skarnes WC, et al. Endoplasmic reticulum stress induction of the Grp78\/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol. 2005;25:4529\u201340. https:\/\/doi.org\/10.1128\/MCB.25.11.4529-4540.2005.","journal-title":"Mol Cell Biol"},{"key":"476_CR40","doi-asserted-by":"publisher","unstructured":"Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, Russo AE, et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle. 2009. https:\/\/doi.org\/10.4161\/cc.8.9.8314.","DOI":"10.4161\/cc.8.9.8314"},{"key":"476_CR41","doi-asserted-by":"publisher","unstructured":"Aggarwal BB, Sethi G, Baladandayuthapani V, Krishnan S, Shishodia S. Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem. 2007. https:\/\/doi.org\/10.1002\/jcb.21500.","DOI":"10.1002\/jcb.21500"},{"key":"476_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0245-2","author":"U McDermott","year":"2018","unstructured":"McDermott U. Cancer cell lines as patient avatars for drug response prediction. Nat Genet. 2018. https:\/\/doi.org\/10.1038\/s41588-018-0245-2.","journal-title":"Nat Genet"},{"key":"476_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/v10020098","author":"E Fanunza","year":"2018","unstructured":"Fanunza E, Frau A, Sgarbanti M, et al. Development and validation of a novel dual luciferase reporter gene assay to quantify ebola virus VP24 inhibition of IFN signaling. Viruses. 2018. https:\/\/doi.org\/10.3390\/v10020098.","journal-title":"Viruses"},{"key":"476_CR44","doi-asserted-by":"crossref","unstructured":"Mouldy S, Sioud M (2006) Main approaches to target discovery and validation. In: Target discovery and validation reviews and protocols.","DOI":"10.1385\/1597452084"},{"key":"476_CR45","doi-asserted-by":"publisher","unstructured":"An WF, Tolliday N. Cell-based assays for high-throughput screening. Mol Biotechnol. 2010. https:\/\/doi.org\/10.1007\/s12033-010-9251-z.","DOI":"10.1007\/s12033-010-9251-z"},{"key":"476_CR46","doi-asserted-by":"publisher","unstructured":"Shaw HV, Koval A, Katanaev VL. A high-throughput assay pipeline for specific targeting of frizzled GPCRs in cancer. Methods Cell Biol. 2019. https:\/\/doi.org\/10.1016\/bs.mcb.2018.08.006.","DOI":"10.1016\/bs.mcb.2018.08.006"},{"key":"476_CR47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003822","author":"M Tian","year":"2019","unstructured":"Tian M, Zeng T, Liu M, et al. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases. J Biol Chem. 2019. https:\/\/doi.org\/10.1074\/jbc.RA118.003822.","journal-title":"J Biol Chem"},{"key":"476_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat9446","author":"Y Antonova-Koch","year":"2018","unstructured":"Antonova-Koch Y, Meister S, Abraham M, et al. Open-source discovery of chemical leads for next-generation chemoprotective antimalarials. Science. (80-). 2018. https:\/\/doi.org\/10.1126\/science.aat9446.","journal-title":"Science (80-)"},{"key":"476_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2018.1540474","author":"AEY Sarwono","year":"2019","unstructured":"Sarwono AEY, Mitsuhashi S, Bin KMH, et al. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening. J Enzyme Inhib Med Chem. 2019. https:\/\/doi.org\/10.1080\/14756366.2018.1540474.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"476_CR50","doi-asserted-by":"publisher","unstructured":"Tomasello L, Cluts L, Croce CM. Experimental validation of microRNA targets: luciferase reporter assay. Methods Mol. Biol. 2019. https:\/\/doi.org\/10.1007\/978-1-4939-9207-2_17.","DOI":"10.1007\/978-1-4939-9207-2_17"},{"key":"476_CR51","doi-asserted-by":"publisher","unstructured":"Godfraind T. Discovery and development of calcium channel blockers. Front Pharmacol. 2017;8:286. https:\/\/doi.org\/10.3389\/fphar.2017.00286.","DOI":"10.3389\/fphar.2017.00286"},{"key":"476_CR52","doi-asserted-by":"publisher","unstructured":"Johnson R, Dludla P, Mabhida S, Benjeddou M, Louw J, February F. Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review. Heart Fail Rev. 2019. https:\/\/doi.org\/10.1007\/s10741-018-09765-y.","DOI":"10.1007\/s10741-018-09765-y"},{"key":"476_CR53","unstructured":"Ruffolo RR Jr, Boyle DA, Venuti RP, Lukas MA. Preclinical and clinical pharmacology of carvedilol. J Human Hypertension. 1993;7 Suppl 1:S2-15. PMID: 8487245."},{"key":"476_CR54","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.jpp_34_17","author":"G Grassi","year":"2018","unstructured":"Grassi G, Robles N, Seravalle G, Fici F. Lercanidipine in the management of hypertension: an update. J Pharmacol Pharmacother. 2018. https:\/\/doi.org\/10.4103\/jpp.jpp_34_17.","journal-title":"J Pharmacol Pharmacother"},{"key":"476_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep39838","author":"YM Yoon","year":"2016","unstructured":"Yoon YM, Lee JH, Yun SP, et al. Tauroursodeoxycholic acid reduces ER stress by regulating of Akt-dependent cellular prion protein. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep39838.","journal-title":"Sci Rep"},{"key":"476_CR56","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.12-46","author":"T Kamiya","year":"2013","unstructured":"Kamiya T, Hara H, Adachi T. Effect of endoplasmic reticulum (ER) stress inducer thapsigargin on the expression of extracellular-superoxide dismutase in mouse 3T3-L1 adipocytes. J Clin Biochem Nutr. 2013. https:\/\/doi.org\/10.3164\/jcbn.12-46.","journal-title":"J Clin Biochem Nutr"},{"key":"476_CR57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5441","author":"S Baritaki","year":"2014","unstructured":"Baritaki S, Katsman A, Chatterjee D, et al. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol. 2014. https:\/\/doi.org\/10.4049\/jimmunol.179.8.5441.","journal-title":"J Immunol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-020-00476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-020-00476-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-020-00476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T18:04:33Z","timestamp":1614017073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-020-00476-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1007\/s13577-020-00476-x","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"13 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. The authors disclose no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}